Ritodrine Pregnancy and Breastfeeding Warnings
Brand names: Yutopar
Ritodrine Pregnancy Warnings
Ritodrine has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetotoxicity. There are no controlled data in human pregnancy. Neonatal hypoglycemia, tachycardia, and ileus have been reported. Rarely, ketoacidosis resulting in fetal death has been reported. Ritodrine is only recommended for use during pregnancy when benefit outweighs risk.
Ritodrine Breastfeeding Warnings
There are no data on the excretion of ritodrine into human milk.
See also
References for pregnancy information
- (2001) "Product Information. Yutopar (ritodrine)." Astra-Zeneca Pharmaceuticals
References for breastfeeding information
- (2001) "Product Information. Yutopar (ritodrine)." Astra-Zeneca Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.